Genzyme Corp. (Nasdaq: GENZ) rejected Sanofi-Aventis' $18.5 billion acquisition offer as too low. Shares of Genzyme climbed $2.29 to close at $69.91.
Genzyme Rejects Sanofi-Aventis' $18.5 Billion Offer
August 30, 2010 at 17:45 PM EDT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.